Center Laboratories, Inc. (4123.TWO)

TWD 34.0

(-0.73%)

Market Cap (In TWD)

24.49 Billion

Revenue (In TWD)

1.39 Billion

Net Income (In TWD)

-995.42 Million

Avg. Volume

1.06 Million

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
40.1-59.6
PE
-21.94
EPS
-1.55
Beta Value
0.78
ISIN
TW0004123005
CUSIP
-
CIK
-
Shares
720424000.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Ms. Su-Chi Wang
Employee Count
-
Website
https://www.centerlab.com.tw
Ipo Date
2007-12-31
Details
Center Laboratories, Inc. engages in the manufacture and trading of various medicines in Taiwan. It engages in the research and development of small molecule drugs; manufacture and sale of pharmaceuticals; development of proteins and antibodies; and pharmaceutical CDMO, medical device, nutritional health and agribiotechnology, stem cell and immune cell therapy, and industry investment fund and venture capital businesses. The company was founded in 1959 and is headquartered in Taipei, Taiwan.